Vancleave v. Linquist

District Court, E.D. Texas·Decided May 14, 2024·No. 4:23-cv-00797·Unknown

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF TEXAS SHERMAN DIVISION

§ JENNIFER LYNN VANCLEAVE and § KATHRYN ANN BOWLDS, § § Plaintiffs, § § v. § Civil Action No. 4:23-cv-797-KPJ § BRYAN EDWARD LINQUIST and XPO § LOGISTICS FREIGHT INC., § § Defendants. §

MEMORANDUM OPINION AND ORDER

On February 14, 2024, Plaintiffs Jennifer Lynn Vancleave (“Vancleave”) and Kathryn Ann Bowlds (“Bowlds”) (collectively, “Plaintiffs”) filed the Objections to and Motion to Quash Defendants’ Depositions upon Written Questions and Motion for Protective Order (the “Motion to Quash”) (Dkt. 27), to which Defendants Bryan Edward Linquist (“Linquist”) and XPO Logistics Freight Inc. (“XPO”) (collectively, “Defendants”) filed a response. On March 25, 2024, the Court ordered the parties to submit a joint letter brief detailing the remaining discovery issues related to the Motion to Quash (Dkt. 27), as well as several other discovery issues pending before the Court. See Dkt. 33 at 2. On March 28, 2024, the parties submitted the Joint Letter Brief (Dkt. 34), which substantially narrowed the issues remaining in dispute. See Dkt. 34. On April 22, 2024, the Court held a hearing regarding these issues. See Minute Entry for April 22, 2024. In the Joint Letter Brief (Dkt. 34), Plaintiffs request that the Court quash a subpoena duces tecum (the “Subpoena”) served by Defendants on third party Deposition Solutions, LLC (“Deposition Solutions”). See Dkt. 34 at 3. The Subpoena requests: “All deposition transcripts involving Dr. Frank Fichtel being the witness for Thomas J. Henry Law.” Dkt. 26-1 at 11. Plaintiffs argue that the production of these transcripts would reveal “confidential” and “privileged” information protected by the Health Insurance Portability and Accountability Act (“HIPAA”). Dkt. 34 at 3. Plaintiffs further argue that these transcripts are “not relevant at all.” Id. At the hearing, the Court inquired regarding Plaintiffs’ standing to challenge the Subpoena on behalf of Deposition Solutions. In response, Plaintiffs provided a citation to case law in support

of their position. See Marchlewicz v. Bros. Xpress, Inc., No. 19-cv-996, 2021 WL 397398 (W.D. Tex. Feb. 4, 2021). Upon the Court’s inquiry, Defendants could not provide supporting authority for their position, but they indicated a willingness to do so. The Court also inquired whether the parties were amenable to a protective order to ameliorate any concerns related to the disclosure of confidential medical information. The parties agreed that a protective order was warranted. Finally, the Court inquired regarding the number of depositions given by Dr. Fichtel over the last five years1 in cases where Thomas J. Henry Law represented the plaintiff. Neither party knew the answer to the Court’s question. Thus, even if Plaintiffs had standing to quash the Subpoena, the Court lacked the information necessary to determine whether the discovery sought by the

Subpoena is proportional to the needs of this case. Based on the foregoing issues, the Court ordered the parties to file a joint supplemental brief. See Dkt. 38 at 3–4. On April 29, 2024, the parties filed the Agreed Motion for Protective Order (Dkt. 39), wherein they attached a proposed protective order with agreed upon language. See Dkt. 39-1. That same day, the parties filed the Joint Supplemental Brief (Dkt. 40), wherein Defendants argue “that Plaintiffs do not have standing to challenge the [S]ubpoena served on . . . Deposition Solutions.”

1 At the hearing, Defendants represented that the Subpoena was limited in scope to the prior five years. The Court finds no such limiting language in the Subpoena. Dkt. 40 at 2.2 Besides providing a citation to case law at the hearing, Plaintiffs assert no additional argument regarding their standing to quash the Subpoena. On May 3, 2024, the Court entered the Protective Order (Dkt. 43) containing the parties’ agreed upon language. See Dkt. 43. STANDING “Absent possession of the documents at issue or a personal right or privilege with respect

to the subpoenaed materials, a party generally does not have standing to quash a subpoena duces tecum issued to a third party.” E.g., La. Corral Mgmt., LLC v. Axis Surplus Ins. Co., 650 F. Supp. 3d 491, 500 (E.D. La. 2023) (citations omitted). A “personal right or privilege” is “generally found . . . when the party had an evidentiary privilege as to the documents.” Jez v. Dow Chem. Co., 402 F. Supp. 2d 783, 785 (S.D. Tex. 2005) (collecting cases). Plaintiffs raise three bases for quashing the Subpoena. First, Plaintiffs argue that some of the deposition transcripts sought by the Subpoena are subject to protective orders issued in other cases. See Dkts. 27 at 2; 34 at 3. Second, Plaintiffs contend that the deposition transcripts sought by the Subpoena are not relevant to any claim or defense and, thus, are not discoverable. See

Dkts. 27 at 4–5; 34 at 3. Third, Plaintiffs argue that discovery of the deposition transcripts would violate HIPAA and the privacy rights of patients in other, unrelated cases. See Dkts. 27 at 3; 34 at 3. The Court considers each of these arguments in turn. Plaintiffs first argue that some of the deposition transcripts sought by the Subpoena are subject to protective orders preventing their disclosure. See Dkt. 34 at 3. Indeed, Plaintiffs represent that protective orders have been issued in fourteen cases where Dr. Fichtel was deposed, and Thomas J. Henry Law was the plaintiff’s counsel. See Dkt. 40 at 1. However, Plaintiffs have

2 Defendants also argue that this issue is now moot because they propounded the same discovery requests to Plaintiffs. See Dkt. 40 at 2. While this may be true, it is unclear why a duplicative request necessarily renders the Subpoena moot. Furthermore, Defendants do not represent that they rescinded or withdrew the Subpoena. Thus, the Court considers this issue to be ripe for a decision. not provided these protective orders to the Court, precluding the determination of whether, or to what extent, the Subpoena should be quashed or modified on this basis. In any event, it is unclear how Plaintiffs, who are strangers to these cases, have a “personal right or privilege with respect the subpoenaed materials.” See La. Corral Mgmt., LLC, 650 F. Supp. 3d at 500. Furthermore, the entity potentially subject to these protective orders—Deposition Solutions—objected on this very

basis and declined to produce any deposition transcripts as a result. See Dkt. 34-1 at 3 (“The requested documents are potentially covered by any number of privately negotiated protective orders entered into by other parties in other cases, some of which may impose notice requirements on [Deposition Solutions].”). For these reasons, Plaintiffs lack standing to quash the Subpoena on the grounds that the production of the deposition transcripts would violate the protective orders in other cases. Next, Plaintiffs argue that the deposition transcripts sought by the Subpoena are not relevant and, therefore, not discoverable. See Dkts. 27 at 4–5; 34 at 3. “A party generally ‘cannot challenge a Rule 45 subpoena directed to a third party on the basis that . . . the subpoena is overly

Free access — add to your briefcase to read the full text and ask questions with AI

Vancleave v. Linquist, (E.D. Tex. 2024).

Vancleave v. Linquist (Vancleave v. Linquist) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Jez v. Dow Chemical Co., Inc.
402 F. Supp. 2d 783 (S.D. Texas, 2005)